Product Overview
Trivastal LA 50mg is a sustained-release (LA: Long-Acting) formulation of Piribedil, a potent dopamine agonist. It is extensively used for the treatment of Parkinson’s disease as well as other disorders of the brain that are caused by dopamine deficiency. Trivastal LA provides a prolonged effect on the body through a once-a-day dose to improve patient compliance, as well as providing stable control of symptoms throughout the entire day.
Piribedil offers a distinct pharmaceutical profile that not only enhances dopamine receptors but also increases cerebral blood flow, which makes it a great treatment for non-motor and motor symptoms that are associated with Parkinsonism.
Composition
- Active Ingredient: Piribedil – 50mg per capsule (Long-acting formulation)
- Formulation: Sustained-release capsule (LA)
- Brand Name: Trivastal LA
- Manufacturer: [Specify Manufacturer]
Mechanism of Action
Piribedil is a specific dopamine D2 and D3 receptor agonist that mimics the action of dopamine within the brain. Dopamine is one of the neurotransmitters essential to controlling the flow of movement, mood, and motivation. When you suffer from Parkinson’s disease, dopamine-producing cells gradually degenerate and cause motor signs such as tremors, rigidity, and bradykinesia.
Trivastal LA 50mg works by:
- Stimulating dopamine receptors directly and compensating for the loss of dopamine
- Facilitating the dopaminergic system within the basal ganglia and the other motor control centres
- Improved cerebral circulation could improve cognition and slow the progression of neurodegenerative impairment.
The ability to sustain-release ensures constant release of Piribedil and prevents fluctuations in the levels of the drug that could make symptoms worse or trigger adverse side effects.
Indications and Uses
Trivastal LA 50mg is indicated for:
- Parkinson’s disease: Both idiopathic Parkinson’s and secondary Parkinsonism
- Restoration of motor function: Reduces tremor, stiffness, and slow movements
- Adjunct therapy: It can be combined with Levodopa and other antiparkinsonian medications for better control of symptoms
- Cognitive disorders related to cerebral insufficiency: Its vasodilatory effect is responsible for improving the brain’s circulation
- Some instances of cardiovascular Parkinsonism
Dosage and Administration
Starting Dose:
- A typical dose for starting can be 50 mg every day and preferably early in the morning.
- The dosage can be increased gradually according to the patient’s response and tolerance, in increasing doses to 50 mg every 3 to 7 days.
- The dosage that is recommended for the maximum amount is generally not more than 300 mg daily, divided into three dosages.
Administration Tips:
- Consume capsules during or immediately after meals to ease gastrointestinal discomfort.
- Take a full swallow of the water. Don’t chew or crush.
- A consistent timing can help ensure that drug levels remain constant.
Special Populations:
- Elderly: The need for dose adjustments can be because of sensitivity or comorbidities.
- Patients with liver or kidney impairment: Monitoring and careful titration are recommended.
Benefits of Trivastal LA 50mg
- Improved motor function: Reducing tremors, rigidity, and slowness in movement.
- Reduced “off” periods: The smooth control of symptom levels in between doses is thanks to sustained-release.
- Improved cerebral blood flow: It may improve cognitive functioning and decrease fatigue.
- Good tolerability: It is generally well-tolerated and has lower side effects compared with Levodopa.
- Once-daily dosing: Improves compliance of patients and improves their convenience.
- Could delay the requirement for Levodopa during the initial stages of Parkinson’s disease.
Precautions and Contraindications
Precautions:
- Be cautious with patients who have a history of hallucinations or psychosis. Dopamine agonists can increase the severity of these symptoms.
- Monitor for impulse control disorders (e.g., compulsive gambling, hypersexuality).
- Patients must be aware of the possibility of sleepiness or sudden incidents. Avoid operating machinery or driving when they are affected.
- Be cautious when using this medication when treating heart disease due to the possibility of a vasodilatory effect.
- Keep track of blood pressure on a regular basis since orthostatic hypotension (low blood pressure while standing) could occur.
Contraindications:
- Hypersensitivity is known in the presence of Piribedil or any of its excipients
- The history of the pheochromocytoma (a tumor that could alter blood pressure)
- Severe psychiatric disorders
- Women who are pregnant or nursing, except when clearly required and recommended by a physician
Possible Side Effects
Although Trivastal LA 50mg is usually easily tolerated, some unwanted reactions may happen:
Common Side Effects:
- Nausea and vomiting
- Headache and dizziness
- Fatigue or somnolence (sleepiness)
- Orthostatic hypotension (feeling lightheaded on standing)
- Gastrointestinal upset
Less Common but Serious Side Effects:
- Hallucinations or psychotic symptoms
- Dyskinesia (involuntary movements)
- Impulse control disorders (compulsive behaviors)
- Sudden onset of sleep without warning
- Allergic reactions such as rash or swelling
If you notice any unusual or severe symptoms arise, you should seek immediate medical attention.
Drug Interactions
- Levodopa: Sometimes, they are used in conjunction. Piribedil could enhance the effect of Levodopa; however, it is important to monitor the potential for more side effects.
- Antipsychotics: It may reduce the effectiveness of Piribedil because of dopamine blockade.
- Antihypertensive drugs: Additive blood pressure-lowering effects; monitor blood pressure.
- CNS depressants: May increase sedation.
Make sure you inform your physician of any medications or supplements you take.
Storage Instructions
- Keep in a room that is dry and cool less than 30°C.
- Place the medicine in the original container out of direct sunlight and moisture.
- Make sure that the area is safe for young children.
- Use only beyond the expiration date of the packaging.
Frequently Asked Questions (FAQs)
How soon will Trivastal LA 50mg start working?
A reduction in symptoms could be felt in two to three weeks. However, optimal results generally take a couple of weeks because of dose adjustment.
Can Trivastal LA be used alone for Parkinson’s disease?
Yes, in the beginning, it is especially effective in Parkinson’s. The treatment can also be paired with Levodopa or any other medication in the course of the disease.
Is Trivastal LA addictive?
No, there is no need to worry, Piribedil is not addictive. However, you should be aware of problems with impulse control that are related to dopamine receptors.
Can I stop taking Trivastal LA suddenly?
No, sudden discontinuation may worsen symptoms. Always consult your doctor for gradual dose reduction.
Are there any dietary restrictions while taking this medication?
There are no specific limitations; having it in conjunction with food can help lessen symptoms of nausea.
Summary
Trivastal LA 50mg (Piribedil) is an important medication for the treatment of Parkinson’s disease as well as related neurologic disorders. Its dopamine receptor antagonist action, coupled with a sustained release formulation, provides:
- Effective symptom control
- Convenient once-daily dosing
- A favorable safety profile
In addition to improving motor function and other non-motor symptoms by reducing non-motor and motor symptoms, Trivastal LA improves the quality of life of those suffering from Parkinsonism.
Take Trivastal LA 50mg under medical supervision and adhere to prescription dosages and guidelines. A timely diagnosis and early treatment are essential to effectively managing Parkinson’s as well. Piribedil is still a useful alternative in the arsenal of therapeutics.
Disclaimer: This information is meant to be used for informational and educational purposes only. It is not meant to substitute for professional medical guidance. Talk to your doctor before making any changes to or additions to your treatment regimen.



















Reviews
There are no reviews yet.